A patient clinically diagnosed as multiple system atrophy harboring LRRK2 p.G2019S

A patient clinically diagnosed as multiple system atrophy harboring LRRK2 p.G2019S

Bibliographic Details
Main Authors:	Shoichiro Ando, Takuya Konno, Tomohiko Ishihara, Hideki Hayashi, Natsumi Saito, Kenya Nishioka, Nobutaka Hattori, Zbigniew K. Wszolek, Osamu Onodera
Format:	Article
Language:	English
Published:	Elsevier 2019-01-01
Series:	Clinical Parkinsonism & Related Disorders
Online Access:	http://www.sciencedirect.com/science/article/pii/S2590112519300283

Similar Items

A Novel LRRK2 Variant p.G2294R in the WD40 Domain Identified in Familial Parkinson’s Disease Affects LRRK2 Protein Levels
by: Jun Ogata, et al.
Published: (2021-04-01)

LRRK2 p.G2019S Mutation Is Not Common among Alzheimer’s Disease Patients in Brazil
by: Cíntia Barros Santos-Rebouças, et al.
Published: (2009-01-01)

Isolated nigral degeneration without pathological protein aggregation in autopsied brains with LRRK2 p.R1441H homozygous and heterozygous mutations
by: Masashi Takanashi, et al.
Published: (2018-10-01)

LRRK2 and the p.G2019S mutation in neuronal and systemic response to induced α-synuclein pathobiology
by: MacIsaac, Sarah
Published: (2016)

Astrocytic atrophy as a pathological feature of Parkinson’s disease with LRRK2 mutation
by: Paula Ramos-Gonzalez, et al.
Published: (2021-03-01)

Non-genetically modified models exhibit TARDBP mRNA increase due to perturbed TDP-43 autoregulation
by: Akihiro Sugai, et al.
Published: (2019-10-01)

Progressive Supranuclear Palsy with Predominant Cerebellar Ataxia
by: Shoichiro Ando, et al.
Published: (2020-01-01)

Expression analysis of Lrrk1, Lrrk2 and Lrrk2 splice variants in mice.
by: Florian Giesert, et al.
Published: (2013-01-01)

Natural Compounds Attenuate Denervation-Induced Skeletal Muscle Atrophy
by: Tomohiko Shirakawa, et al.
Published: (2021-08-01)

Robustness and Vulnerability of the Autoregulatory System That Maintains Nuclear TDP-43 Levels: A Trade-off Hypothesis for ALS Pathology Based on in Silico Data
by: Akihiro Sugai, et al.
Published: (2018-02-01)

In vitro genome editing rescues parkinsonism phenotypes in induced pluripotent stem cells-derived dopaminergic neurons carrying LRRK2 p.G2019S mutation
by: Kuo-Hsuan Chang, et al.
Published: (2021-09-01)

Dynamic and redundant regulation of LRRK2 and LRRK1 expression
by: Dawson Ted M, et al.
Published: (2007-11-01)

LRRK2 kinase activity is dependent on LRRK2 GTP binding capacity but independent of LRRK2 GTP binding.
by: Jean-Marc Taymans, et al.
Published: (2011-01-01)

Generation of an induced pluripotent stem cell line (DANi-011A) from a Parkinson's disease patient with a LRRK2 p.G2019S mutation
by: Muwan Chen, et al.
Published: (2020-05-01)

CRUD-PG
by: Beatriz Piñeiro Veitia, et al.
Published: (2011-11-01)

A Critical LRRK at the Synapse? The Neurobiological Function and Pathophysiological Dysfunction of LRRK2
by: Naila Kuhlmann, et al.
Published: (2020-08-01)

Generation of an induced pluripotent stem cell line (CSC-41) from a Parkinson's disease patient carrying a p.G2019S mutation in the LRRK2 gene
by: Ana Marote, et al.
Published: (2018-04-01)

Protective role of the PG1036-PG1037-PG1038 operon in oxidative stress in Porphyromonas gingivalis W83.
by: Leroy G Henry, et al.
Published: (2013-01-01)

Lack of correlation between the kinase activity of LRRK2 harboring kinase-modifying mutations and its phosphorylation at Ser910, 935, and Ser955.
by: Genta Ito, et al.
Published: (2014-01-01)

P.G. BAYDALA
Published: (2016-02-01)

Cryo-EM analysis of homodimeric full-length LRRK2 and LRRK1 protein complexes
by: Kushal Sejwal, et al.
Published: (2017-08-01)

Elevated LRRK2 autophosphorylation in brain-derived and peripheral exosomes in LRRK2 mutation carriers
by: Shijie Wang, et al.
Published: (2017-11-01)

Efficient viral delivery of Cas9 into human safe harbor
by: Hideki Hayashi, et al.
Published: (2020-12-01)

PG&C: BREVE RETROSPECTO
by: Jorge de Oliveira Gomes, et al.
Published: (2013-12-01)

The PNN and PG 1159 connection
by: Kawaler S. D.
Published: (1995-09-01)

CMT2A Harboring Mitofusin 2 Mutation with Optic Nerve Atrophy and Normal Visual Acuity
by: Guerriero S, et al.
Published: (2020-02-01)

New Quantum Codes Constructed by Quantum Caps in PG(3,9) and PG(4,9)
by: Husheng Li, et al.
Published: (2020-01-01)

“LRRK2: Autophagy and Lysosomal Activity”
by: Marta Madureira, et al.
Published: (2020-05-01)

Models for LRRK2-Linked Parkinsonism
by: Tianxia Li, et al.
Published: (2011-01-01)

Computational analysis of the LRRK2 interactome
by: Claudia Manzoni, et al.
Published: (2015-02-01)

Autophagy and LRRK2 in the Aging Brain
by: Federica Albanese, et al.
Published: (2019-12-01)

The Role of LRRK2 in Crohn's Disease
by: Fernandez-Hernandez, Heriberto
Published: (2018)

Splice-Switching Antisense Oligonucleotides Reduce LRRK2 Kinase Activity in Human LRRK2 Transgenic Mice
by: Joanna A. Korecka, et al.
Published: (2020-09-01)

Investigation of Roles for exoPG1 and exoPG2 in Pollen Development/Elongation of Oryza sativa
by: Chieh-Yu Hung, et al.
Published: (2015)

The Parkinson's Disease-Associated Protein Kinase LRRK2 Modulates Notch Signaling through the Endosomal Pathway.
by: Yuzuru Imai, et al.
Published: (2015-09-01)

Identification of Disease-Associated Variants by Targeted Gene Panel Resequencing in Parkinson's Disease
by: Kensuke Daida, et al.
Published: (2020-09-01)

Conic Parameterization in PG(2,25)
by: Emad Bakr Al-Zangana, et al.
Published: (2018-11-01)

Wet Observations of PG 1159–035
by: Costa J. E. S., et al.
Published: (2003-03-01)

Some new surfaces with pg = 0
by: Barlow, Rebecca Nora
Published: (1982)

Reflection Effect in PG 1336-018
by: Zola S.
Published: (2000-06-01)